Skip to content

Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data (ECoG)

Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation With Imaging Data

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05875935
Acronym
ECoG
Enrollment
1
Registered
2023-05-25
Start date
2021-12-17
Completion date
2022-05-31
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electrocorticography, Glioma, Karnofski Index

Brief summary

This study proposes to analyze data from intraoperative ECoG recordings acquired during wakefulness interventions in order to identify the connection networks involved in cognitive functions. This study also proposes to correlate the ECoG data with the imaging data and to analyze the disturbances of the electrophysiological signals induced by the cortical and subcortical brain lesions: this will make it possible to establish a more detailed mapping of the tumor areas and to compare disturbances recorded to those recorded in healthy areas. Thus, this approach should make it possible to improve the quality of excision of glial lesions located in eloquent areas, while reducing the risk of neurological sequelae and thus improve the survival and quality of life of patients.

Interventions

PROCEDUREECoG : electrocorticography

The skull and the dura are opened under general anesthesia and the two grids of 64 cortical electrodes will be applied to the cortex, one facing the glial lesion, and the other at a distance from the glial lesion in the so-called area. "Healthy" (non-tumor), before the patient wakes up. They consist of 8 recording slides each comprising 8 electrodes of 2 mm in diameter each spaced 0.5 mm (DispoMed®, USA).

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER
European Clinical Trial Experts Network
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman over 18 years-old * Subject with a non-recurrent glial lesion requiring surgery in vigilant condition; * Brain lesion located in the functional zone; * Major not protected within the meaning of the law; * Subject affiliated to a Health Insurance scheme; * No medical contraindication to performing an MRI (pacemaker); * No medical contraindication to surgery and anesthesia; * Karnofski index\> 70; * Subject having signed an informed consent.

Exclusion criteria

* Minor subject, pregnant or breastfeeding woman; * Major subject subject under measure of legal protection, guardianship or deprived of liberty by judicial or administrative decision; * Subject hospitalized without consent; * Subject treated with antipsychotics (neuroleptic or lithium); * Subject who has already been treated for his glial lesion by surgery and / or radiotherapy; * Subject refusing to sign an informed consent. * Subject wishing to discontinue participation in the study before completion; * Subject for which the surgical intervention and / or the ECoG recording could not be carried out after admission to the operating room (whatever the reason).

Design outcomes

Primary

MeasureTime frameDescription
electrocorticographic recordings12 monthsIntraoperative ECoG recordings (raw signals) acquired during awake surgery which in clinical practice couples cortical stimulation and simultaneous ECoG recordings with behavioral tests. The regions defined as electrophysiologically "connected" to the stimulated region will be those for which an afterdischarge is recorded (short-duration rhythmic activity following the stimulation) and/or a cortico-cortical evoked potential is obtained after a average of 5 successive stimulations.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026